ZyLET

Active Ingredient(s): Loteprednol + Tobramycin
FDA Approved: * December 14, 2004
Pharm Company: * BAUSCH AND LOMB
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



ZyLET Overview

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used to treat inflammations of the eye. It is marketed by Bausch and Lomb as Lotemax[1] and Loterex. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Interactions 5 Pharmacology 5.1 Mechanism of action 5.2 Pharmacokinetics 5.3 Retrometabolic drug design 6 Chemistry 6.1 Chemical synthesis 7 References 8 Further reading Medical uses Applications for this drug include the reduction ...

Read more ZyLET Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Loteprednol

Recent ZyLET Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Loteprednol + Tobramycin
  • Suspension: 0.5% + 0.3%
  • Suspension/drops: 0.5% + 0.3%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for ZyLET: (1 result)

Sorted by National Drug Code
  • 24208-358 Zylet Ophthalmic Suspension/ Drops by Bausch & Lomb Incorporated

Drugs with one or more similar ingredients: (16 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA